Atnaujinkite slapukų nuostatas

Lung in Autoimmune Diseases, Volume 17 [Minkštas viršelis]

Edited by (Full Professor and Head of Rheumatology Unit, University of Messina, Messina, Italy), Edited by (Specialist in Internal Medicine and Rheumatology, University of Barcelona, Barcelona, Catalonia, Spain), Edited by (Pneumology Department, Hospital Clinic de)
  • Formatas: Paperback / softback, 228 pages, aukštis x plotis: 229x152 mm, weight: 1000 g, 70 illustrations (50 in full color); Illustrations
  • Serija: Handbook of Systemic Autoimmune Diseases
  • Išleidimo metai: 17-Feb-2022
  • Leidėjas: Elsevier - Health Sciences Division
  • ISBN-10: 0323910831
  • ISBN-13: 9780323910835
Kitos knygos pagal šią temą:
  • Formatas: Paperback / softback, 228 pages, aukštis x plotis: 229x152 mm, weight: 1000 g, 70 illustrations (50 in full color); Illustrations
  • Serija: Handbook of Systemic Autoimmune Diseases
  • Išleidimo metai: 17-Feb-2022
  • Leidėjas: Elsevier - Health Sciences Division
  • ISBN-10: 0323910831
  • ISBN-13: 9780323910835
Kitos knygos pagal šią temą:
The Lung in Autoimmune Diseases, Volume Seventeen identifies and describes the role of the lung in the most common systemic autoimmune diseases. From disease patterns, prognosis and risks to treatment, this book provides a comprehensive approach for the role of the lung in autoimmune diseases and the influence of autoimmune disease on the lung’s functionality. In recent years, there is increasing knowledge in the field, including lung infection in early disease stages, mechanisms involved in lung damage, and new treatments. Recognition of lung involvement and implementation of some specific therapies is an important issue for clinicians dealing with systemic autoimmune diseases.
Contributors xi
1 Interstitial pneumonia with autoimmune features
Anthony J. Esposito
Paul F. Dellaripa
Epidemiology
5(1)
IPAF classification
6(4)
Mechanisms of disease
10(2)
Prognosis
12(1)
Treatment considerations
13(1)
Criticisms and potential shortcomings of the IPAF designation
14(2)
Conclusions
16(1)
Take home message
16(1)
References
16(5)
2 Interstitial lung disease and rheumatoid arthritis
Fabiola Atzeni
Cesare Siragusano
Jose A. Gomez-Puerta
Introduction
21(1)
Risk factors and pathogenesis
21(2)
Clinical manifestations
23(1)
Diagnostic imaging
23(2)
Different diagnostic methods
25(1)
Therapy
26(7)
Conclusions
33(1)
Take-home messages
33(1)
References
33(8)
3 Lung involvement in SLE
Laurent Arnaud
Gerard Espinosa
Pleural involvement
41(1)
Interstitial lung disease
42(3)
Pulmonary arterial hypertension
45(1)
Diffuse alveolar hemorrhage and pulmonary vasculitis
46(1)
Acute lupus pneumonitis
46(2)
Shrinking lung syndrome
48(2)
References
50(5)
4 Sjogren's syndrome and lung involvement
Ilektra Voulgareli
Vasiliki Koulouri
Alexandra Chroneou
Clio P. Mavragani
Introduction
55(1)
Airway disease
56(2)
Interstitial lung disease
58(7)
Other pulmonary manifestations
65(1)
References
66(7)
5 Lung involvement in systemic sclerosis
Corrado Campochiaro
Cosimo Bruni
Sara Tomassetti
Lorenzo Dagna
Marco Matucci-Cerinic
Epidemiology
73(1)
Pathogenesis
74(3)
Clincal presentation
77(1)
Diagnosis of ILD
78(8)
Screening for ILD
86(2)
ILD monitoring and progression
88(1)
Prognosis
89(1)
Treatment
90(4)
COVID-19 and systemic sclerosis
94(1)
Summary
95(1)
Take-home messages
95(1)
References
95(10)
6 Inflammatory myopathy, mixed connective tissue disease, and antisynthetase syndrome
Albert Selva-O'Callaghan
Ernesto Trallero-Aragua's
Introduction
105(1)
The lung in inflammatory myopathies
105(30)
The lung in mixed connective tissue disease
135(3)
References
138(15)
7 Lung involvement in ANCA-associated vasculitis
Sebastian Unizony
Andy Abril
Introduction
153(1)
Pulmonary manifestations shared among all types of AAV
153(5)
Pulmonary manifestations primarily seen in CPA and EGPA
158(1)
Pulmonary manifestations primarily seen in GPA
159(1)
Pulmonary manifestations primarily seen in EGPA
159(1)
Treatment of lung involvement in ANCA-associated vasculitis
160(2)
Conclusions
162(1)
References
163(6)
8 The lung in autoimmune diseases: sarcoidosis
Robert P. Baughman
Elyse E. Lower
Introduction
169(1)
Lymphatic involvement
169(3)
Parenchymal lung involvement
172(2)
Pulmonary vascular involvement
174(2)
Diagnosis of sarcoidosis
176(2)
Treatment
178(4)
Conclusion
182(1)
Take home messages
182(1)
References
182(7)
9 COVID-19 and lung involvement
Jin-Seok You
Rosa Faner
Oriol Sibila
Jacobo Sellare's
Introduction
189(1)
Epidemiology
190(1)
Virology
191(1)
Transmission
191(1)
Pathogenesis
192(3)
Clinical features
195(3)
Laboratory findings
198(1)
Imaging findings
198(1)
Pathology findings
198(2)
Diagnosis
200(1)
Management
201(5)
Conclusion
206(1)
Take-home messages
206(1)
References
207(6)
Index 213
Fabiola Atzeni, MD, PhD is currently Full Professor and Head of the Rheumatology Unit, University of Messina, Messina, Italy. Her clinical and research interest lies in immunotherapies in autoimmune diseases with particular focus on the investigation and management of differential response to biological therapies in rheumatoid arthritis (RA) and Spondyloarthritis (SpA), and cardiovascular aspects of the different rheumatic diseases with particular emphasis on arteriosclerosis. Dr. Atzeni has co-authored over 400 publications in peer-reviewed journals and several book chapters, is a regular reviewer for several international journals. She is involved in several international and national meetings focused on cardiovascular and infection aspects. Jose A. Gómez-Puerta is a Specialist in Internal Medicine and Rheumatology and Ph.D. in Biopathology by the University of Barcelona. He received further training in the Rheumatology Unit of Guys Hospital, London, UK, and the Lupus Unit, St. Thomas Hospital, London, UK, in 1997 and 2001, respectively. He also finished the Master in Autoimmune Diseases at Universidad de Barcelona and moved for an appointment as Post-Doctoral Research Fellow at Brigham and Womens Hospital at Harvard Medical School, Boston, USA from 2011 to 2014. In 2014, Dr Gómez-Puerta obtained his degree in Master of Public Health at Harvard School of Public Health, Boston. USA. His work has focused on the study of Autoimmune and immune mediated diseases and he has published more than 100 original papers, brief notes or reviews in peer-reviewed journals and over 160 communications in national and international meetings. Currently, Dr Gómez-Puerta is the Head of Department of Rheumatology At Hospital Clinic, Barcelona and associate professor of Rheumatology at University of Barcelona, Spain Dr. Jacobo Sellarés Torres is a recognized researcher in chronic respiratory diseases, and especially in diffuse interstitial lung diseases (DILD). He is coordinator of the Multidisciplinary Program of ILD at Hospital Clķnic, Barcelona, which has been recognized by a variety of organizations, such as the Spanish Society of Pneumology (SEPAR), Orphanet, the European Reference Network (ERN) and the International Sarcoidosis Society (WASOG). Dr. Sellarés Torres belongs to the "Inflammation and repair of respiratory diseases" team of Area 2 of IDIBAPS, Barcelona who specializes in the methodology of systems biology and diseases chronic respiratory diseases. Dr. Sellares is also a research member of the Barcelona Research Network (BRN) and of the CIBER of respiratory diseases (CIBERES), and he actively collaborates in different national and international EPID registration networks. Dr. Sellarés has been a mentor of Respirarory Fellows (Hospital Clinic) since 2019 and reviewer for "Consell Tčcnic de Medicina del Consell Catalą de la Formació Continuada (FC) de les Professions Sanitąries (PS), Departament de Salut de la Generalitat de Catalunya".